Back to search

Iceland· IS-EU/1/17/1227/006-010

Entecavir Viatris

A entecavir product containing entecavirum inn, registered in Iceland by Viatris Limited. The same ATC class is registered in 17 of our 19 countries.

ATC J05AF10

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedEntecavir ViatrisATCJ05AF10REGISTER NO.IS-EU/1/17/1227/006-0…PACKS LISTED0CHECKEDSeptember 29, 2026

Where it is registered

Entecavir is registered in 17 of 19 countries.

Countries holding a registration under ATC J05AF10 (entecavir), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 10 of them publish a price we can compare per daily dose

Entecavir · ATC J05AF10

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of entecavir costs, country by country.

Normalised to the WHO defined daily dose (0.5 mg), the median price runs from $0.20 in United States to $12.37 in Switzerland — a ×61 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Entecavir · price per daily dose (0.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$12.37
  • FR France$7.50
  • IT Italy$4.93
  • US United States$0.20 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Entecavirum INN
Manufacturer
Viatris Limited
Country
Iceland (IS)
ATC code
J05AF10
ATC class
Entecavir
Defined daily dose
0.5 mg, O
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

56 interactions on record for entecavir.

Graded by severity as the source publishes them — 56 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Entecavir · interactions on record

56 records

  • 56 moderate

Most severe, free to view

  • CimetidineA02BA01moderate
  • RanitidineA02BA02moderate
  • FamotidineA02BA03moderate
  • NeomycinA07AA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Entecavir in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All entecavir products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Entecavir Ratiopharm
  • Bulgaria · Ентекавир Pharmascience International Ltd, Ентекавир Зентива
  • Cyprus · Entevirem
  • Czechia · Entecavir Fmk, Entecavir Sandoz
  • Germany · Entecavir Al, Entecavir Amarox
  • Denmark · Edevira, Entecavir Medical Valley
  • Spain · Entecavir Aurovitas, Entecavir Dr. Reddys
  • Finland · Entecavir Stada
  • France · Entecavir Arrow, Entecavir Biogaran
  • United Kingdom (Northern Ireland) · Entecavir Accord-Uk, Entecavir Amarox
  • Greece · Edevira, Entecavir Sandoz
  • Hungary · Entecavir Pharmascience International Ltd, Entecavir Teva
  • Italy · Entecavir Aristo, Entecavir Aurobindo
  • Liechtenstein · Baraclude, Entecavir Accord
  • Lithuania · Entecavir Sandoz
  • Malta · Entecavir Dr. Reddy's, Entecavir Normon
  • Netherlands · Entecavir Amarox, Entecavir Aurobindo
  • Norway · Baraclude, Entecavir Accord
  • Poland · Entecavir Aurovitas, Entecavir Polpharma
  • Portugal · Entecavir Farmoz, Entecavir Generis
  • Romania · Entecavir Labormed, Entecavir Sandoz
  • Sweden · Entecavir Amarox, Entecavir Medical Valley
  • Slovenia · Entekavir Sandoz, Entekavir Stada
  • Slovakia · Entecavir Fmk

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d3fbe55a-0ba0-4ded-8628-217a9a7b0e32
GET /v1/drugs/d3fbe55a-0ba0-4ded-8628-217a9a7b0e32?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmuhúðuð tafla",
  "source": "lyfjastofnun",
  "atc_raw": "J05AF10",
  "marketed": false,
  "strength": "1 mg",
  "ma_number": "EU/1/17/1227/006-010",
  "substance": "Entecavirum INN",
  "other_info": "Ávísun lyfsins er bundin við sérfræðinga í smitsjúkdómum og sérfræðinga í meltingarfærasjúkdómum.",
  "legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
  "ma_issued_serial": "42996"
}

See everything about entecavir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.